Not applicableActive Not RecruitingNCT04472910
What this trial is testing
GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma
Who this might be right for
Resectable Pancreatic Cancer
University Health Network, Toronto 84